Return to Team

Alastair Clemow - Director

Dr. Clemow is currently President & CEO of Regentis Biomaterials, a medical device company based in Princeton, NJ and Or Akiva, Israel. Previously, Dr. Clemow was co-founder and President/CEO of Nexgen Spine (sold to K2M), Gelifex (sold to Synthes Spine, now part of Johnson & Johnson) and Minimally Invasive Surgical Technologies (sold to Mako, now part of Stryker).

Dr. Clemow also has 20 years of senior management experience at Johnson & Johnson including Vice President of Worldwide Business Development for both Ethicon EndoSurgery and Johnson & Johnson Professional. He is currently a director of Medgenics (MDGN:AMEX) and BioMedical Enterprises (a privately held San Antonio company). He holds a PhD from the University of Surrey, UK and an MBA from Columbia University.



Brian Bell – CEO and Director

Doug DuFaux –Technical Director

Bradley Fuhrman – MD, Founder & Chief Medical Officer

Kathy Selover – Regulatory

Diane McMahon – Vice President and Legal Counsel

The strength of any organization is its people. Our independent Board of Directors is composed of some of the most active and well regarded individuals in healthcare; bringing a span of operational, clinical and financial insight

Joel Kanter – Chairman

Brian Bell – CEO and Director

Alastair Clemow – Director

Gene Burleson – Director

Dr. Eugene Bauer – Director

Dean Hautamaki, M.D. – Director

Wayne Hellman, M.D. – Director

Cary W. Sucoff – Director